Marvel's VisionQuest Will Hit Disney Plus in October
Marvel Cinematic Universe star Paul Bettany dropped the news on Tuesday and revealed a clip for the…

USD/JPY exchange rate movements (70% of earnings from Japan, reported in dollars - yen weakness reduces translated earnings)
Japanese government bond yields and credit spreads (affects $100B+ Japan portfolio returns and hedge costs)
U.S. sales growth and persistency rates in core products (accident, hospital indemnity, critical illness)
Benefit ratio trends in both segments (target 45-50% in U.S., 65-70% in Japan)
low - Supplemental insurance exhibits counter-cyclical characteristics as economic uncertainty increases demand for income protection products. Premium revenue is highly recurring with 85-90% persistency, insulating top-line from GDP fluctuations. However, severe recessions can pressure sales growth as employers reduce headcount and limit worksite access. Japan's aging demographics provide structural tailwind regardless of economic cycle.
Rising U.S. and Japanese interest rates are highly positive for Aflac's economics. Higher yields increase net investment income on the $140B+ portfolio (60% Japan, 40% U.S.) as securities mature and reinvest at higher rates. The portfolio has 10-12 year duration, so rate increases flow through gradually. Additionally, rising rates reduce the present value of future policy liabilities, improving statutory capital ratios. However, Aflac hedges 50-70% of yen-denominated earnings back to dollars using currency forwards, and higher U.S. rates relative to Japan increase hedging costs, partially offsetting investment income gains.
Secular shift toward high-deductible health plans and Medicare Advantage could reduce demand for supplemental products if comprehensive coverage improves
Japan's declining working-age population (shrinking 0.5-1.0% annually) pressures new sales growth despite aging demographics increasing claims awareness
Regulatory changes in Japan including potential restrictions on cancer insurance sales practices or commission structures
dividend - Aflac has increased dividends for 41 consecutive years (Dividend Aristocrat status) with 2.3% current yield, attracting income-focused investors. The stock also appeals to value investors given consistent ROE (13-15%), strong free cash flow generation ($2.7B annually), and modest valuation (11.3x EV/EBITDA). Low earnings volatility and defensive characteristics attract risk-averse institutional investors seeking stable compounders.
Trend
+3.9% vs SMA 50 · +19.9% vs SMA 200
Momentum
Distribution pattern detected. More selling days than accumulation over the past 20 sessions. Not a conducive environment for a squeeze.
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2024 | $17.3B $17.2B–$17.5B | — | $7.27 | — | ±1% | High11 |
FY2025 | $17.7B $17.5B–$17.8B | ▲ +2.1% | $7.62 | ▲ +4.7% | ±1% | High10 |
FY2026(current) | $16.9B $16.6B–$17.0B | ▼ -4.5% | $7.09 | ▼ -6.9% | ±2% | High8 |
Dividend per payment — last 8 periods
Marvel Cinematic Universe star Paul Bettany dropped the news on Tuesday and revealed a clip for the…

over 50 million people worldwide have chosen aflac because of our commitment to providing customers with the confidence that comes from knowing they have assistance in being prepared for whatever life may bring. with aflac, whether you're a large business or a small one, you can provide your employees with the kind of benefits they’d expect from a bigger company, helping your business stand out from the crowd. hundreds of thousands of businesses across the united states already make aflac available to their employees—at no direct cost to their company. choose from a wide range of products that can help your employees with health events—from accidents, to disability, to cancer, to life insurance. your employees enjoy benefits from aflac, all employee-paid. please check out aflac.com for more information.
| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
AFL◀ | $116.16 | -0.44% | $58.8B | 12.8 | -883.5% | 2090.8% | 1506 |
| $304.88 | -0.70% | $803.9B | 14.2 | +330.7% | 2039.3% | 1501 | |
| $326.42 | +1.59% | $620.8B | 27.9 | +1134.0% | 5014.5% | 1499 | |
| $499.81 | -1.09% | $439.9B | 28.5 | +1641.6% | 4564.7% | 1492 | |
| $50.78 | -1.48% | $358.7B | 11.6 | -45.1% | 1592.6% | 1500 | |
| $191.90 | +1.51% | $301.4B | 16.5 | +1147.7% | 1466.4% | 1523 | |
| $945.90 | +0.89% | $278.7B | 15.9 | -138.4% | 1373.0% | 1521 | |
| Sector avg | — | +0.04% | — | 18.2 | +455.3% | 2591.6% | 1506 |